Unibest 优贝德
← Back to patent-cliff list

CAS 58-97-9

((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

CodesDIQU-001

Application context (from source-drug indications)

干眼症地夸磷索钠干眼综合征地夸磷索钠干燥性角结膜炎地夸磷索钠

Source drugs (routes using this intermediate)

DrugTierExpiry
地夸磷索钠Diquafosol TetrasodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

地夸磷索钠原研路线steps: 1total yield: /
((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
地夸磷索钠优化路线steps: 2total yield: /
((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphatesodium dihydrogen diphosphate(2:1)diphosphoric acid

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.